If President Trump's threat to impose tariffs on pharmaceutical products goes through, it would have severe consequences for industry R&D efforts, according to a Bayer (OTCPK:BAYZF) pharma executive.

Inflation climbed at the slowest pace since early 2021 in April, surprising economists who anticipated tariff-related increases.

US wholesale prices dropped unexpectedly in April for the first time in more than a year despite President Trump’s sweeping taxes on imports. The producer price index — which tracks inflation before it hits consumers — fell 0.